Search the Newsreel

Why Is IDEXX Laboratories Stock Gaining Tuesday?

IDEXX Laboratories (NASDAQ: IDXX) stock rose on Tuesday after the company reported strong second-quarter results that exceeded Wall Street estimates and subsequently raised its full-year earnings outlook for 2026. The growth was primarily driven by its Companion Animal Diagnostics segment, despite a slight decline …

IDEXX Laboratories Inc Stock Price Live, Charts & News

This article provides live stock information for IDEXX Laboratories Inc (IDXX), including its current share price, historical performance, and key financial metrics like market capitalization, PE ratio, and dividend yield. It also presents the company's balance sheet, income statement, and cash flow data up …

IDEXX Laboratories (IDXX) director granted 49 deferred stock units

IDEXX Laboratories director Joseph L. Hooley acquired 49 deferred stock units on July 30, 2026, under the company's Director Deferred Compensation Plan. These units, valued at $27,280.22 based on a closing share price of $558.80, vest immediately and will be paid in stock after …

IDEXX earnings on deck: Can innovation sustain growth momentum?

IDEXX Laboratories Inc. is set to report its second-quarter earnings, with investors keen to see if the company can maintain its growth trajectory. Analysts anticipate EPS of $3.96 and revenue of $1.20 billion, driven by strong performance in Companion Animal Group diagnostics and adoption …

Should IDEX’s Stronger Q2 2026 Results and Aggressive Buybacks Prompt Action From IEX Investors?

IDEX Corporation reported strong Q2 2026 results with increased sales and net income, alongside continued share buybacks amounting to over a quarter of outstanding shares. The company's investment narrative is buoyed by accelerating orders in data center and semiconductor markets, with significant organic order …

Quantinno Capital Management LP Boosts Stock Holdings in IDEX Corporation $IEX

Quantinno Capital Management LP significantly increased its stake in IDEX Corporation, acquiring an additional 84,465 shares to own a total of 114,480 shares valued at $21.7 million. This move is part of a broader trend of institutional investors, who collectively own 97.96% of IDEX's …

Is IDEX (IEX) Pricey Following Earnings And Buyback News?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. IDEX (IEX) just released second quarter and first half 2026 results, along with an update on its long running share repurchase program, giving …

Should IDEX’s Upgraded 2026 Outlook and Buybacks Require Action From IDEX (IEX) Investors?

IDEX Corporation recently reported its second-quarter 2026 results, with sales rising to US$920.6 million from US$865.4 million and diluted EPS from continuing operations increasing to US$1.93 from US$1.74 a year earlier. Alongside higher earnings, IDEX continued to shrink its share count, having repurchased about …

Renaissance Technologies LLC Makes New $16.02 Million Investment in IDEX Corporation $IEX

Renaissance Technologies LLC has acquired a new stake in IDEX Corporation, purchasing 84,525 shares valued at approximately $16.02 million during the first quarter. This investment makes Renaissance Technologies LLC the owner of 0.11% of IDEX. Other institutional investors have also adjusted their holdings in …

ETFs Investing in IDEXX Laboratories, Inc. Stocks

This article lists various ETFs that include IDEXX Laboratories, Inc. (IDXX) stocks in their holdings. It provides detailed financial information for each ETF, such as market value, weight of IDXX, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV …

IEX4981436 Bond Profile — Key Metrics

This article provides key metrics for the IEX4981436 bond issued by IDEX Corporation. The bond has a 3.0% coupon rate and matures on May 1, 2030, with an outstanding amount of $500 million USD. It also includes a description of IDEX Corporation's business segments.

IDEX Corporation Revenue Breakdown – NYSE:IEX

IDEX Corporation's revenue for the last fiscal year was $3.46 billion USD. The Health & Science Technologies segment was the highest-performing, generating $1.49 billion USD, an increase from $1.29 billion USD in the prior year. The United States contributed the largest share of revenue, …

Enterprise value to EBITDA forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX

The article provides the Enterprise Value to EBITDA forward for IDEXX Laboratories, Inc. (NASDAQ: IDXX). It indicates that the market was closed at the time of data retrieval and that there were no trades. The content primarily focuses on financial data availability for the …

IDEX (IEX) Receives a Buy from RBC Capital

RBC Capital has maintained a Buy rating on IDEX (IEX) with a price target of $280.00. This follows IDEX's strong Q2 earnings report, showing increased revenue and net profit compared to the previous year. Despite a negative sentiment from corporate insiders selling shares, analysts …

IDEX Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:IEX) 2026-07-31

IDEX Corporation published its Q2 2026 earnings call presentation on July 31, 2026. The company reported an EPS of $2.32, beating estimates by $0.21, and revenue of $920.60M, surpassing expectations by $14.22M with a 6.38% year-over-year increase. This presentation provides details discussed during their …

IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for IRIDEX Corp (IRIX) based on its business segments and geographic regions. The company's revenue is primarily derived from its Retina and G6 segments, with a significant portion of its sales coming from the United States and …

IDEX Corp. stock underperforms Friday when compared to competitors

Shares of IDEX Corp. (IEX) fell 1.42% on Friday, closing at $230.45, despite a generally favorable trading session for the broader stock market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains. This decline broke a five-day winning streak for …

Amundi Sells 268,259 Shares of IDEX Corporation $IEX

Amundi reduced its stake in IDEX Corporation by 18.0% in the first quarter, selling 268,259 shares and bringing its total ownership to 1,219,400 shares valued at $231.2 million. Despite this, other institutional investors increased their positions in IDEX. The article notes positive sentiment around …

IDEX Number of Employees 2026 | Employee Count & Headcount Data

IDEX Corp. (IEX) reported approximately 8,717 employees worldwide as of March 2026, marking a 1.4% decline since 2023. Despite this, the company is actively hiring, with 689 job postings in 2026, a 45.4% increase from the previous year. The workforce is primarily concentrated in …

IDEXX Laboratories Inc. Aktie: Bilanz & Finanzlage | Goldesel

IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day

IDEXX Laboratories Inc. (IDXX) shares declined by 1.93% on Thursday, closing at $558.80, despite a generally positive trading session for the broader market. This drop ended a four-day winning streak for the company's stock.

IEX Q2 Deep Dive: Data Center and Semiconductor Demand Drive Momentum, Guidance Raised

IEX Q2 Deep Dive: Data Center and Semiconductor Demand Drive Momentum, Guidance Raised Manufacturing company IDEX (NYSE:IEX) announced better-than-expected revenue in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter's revenue was optimistic at $931.4 million at …

Oppenheimer Adjusts Price Target on IDEX to $265 From $260, Maintains Outperform Rating

Oppenheimer has increased its price target for IDEX (IEX) to $265 from $260, while reiterating an Outperform rating on the stock. This adjustment comes amidst a series of analyst updates for IDEX, including price target changes from BNP Paribas, Stifel, BMO Capital, and Baird, …

Stifel Adjusts Price Target on IDEX to $268 From $257, Maintains Buy Rating

Stifel has increased its price target for IDEX Corporation (IDEX) shares to $268 from $257, while reiterating a Buy rating on the stock. This adjustment reflects the firm's updated valuation for the industrial machinery and equipment company. Several other analysts also revised their price …

OMERS ADMINISTRATION Corp Acquires 6,159 Shares of IDEX Corporation $IEX

OMERS ADMINISTRATION Corp significantly increased its stake in IDEX Corporation, buying an additional 6,159 shares, which raised its holdings by 227.4% to 8,867 shares valued at $1.68 million. Other institutional investors like Deprince Race & Zollo Inc. and Mitsubishi UFJ Asset Management Co. also …

Sei Investments Co. Sells 6,378 Shares of IDEX Corporation $IEX

Sei Investments Co. reduced its stake in IDEX Corporation by 6.2% in the first quarter, selling 6,378 shares, though institutional ownership of IDEX remains high at nearly 98%. This news comes as IDEX reported strong Q2 earnings, exceeding revenue and EPS expectations, and raised …

Idex Is a Cash Compounder With an Impressive Record of Capital Allocation and Margin Expansion

Idex is described as a cash-compounding company with a strong track record of capital allocation and margin expansion. The company owns several niche market-leading businesses that produce a variety of highly engineered, mission-critical products. Idex's wide economic moat is attributed to customer switching costs …

Is IDEXX Laboratories (IDXX) Fairly Valued After Its 2025 Corporate Responsibility Report?

IDEX Corporation Q2 2026 Earnings Call Summary

IDEX Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Organic growth …

IDEX Corp (IEX) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidance

This article first appeared on GuruFocus. Organic Sales Growth: 5% increase. Adjusted EBITDA Margin: Expanded 70 basis points year over year to 28.1%. Adjusted EPS: Grew 12% to $2.32. Organic Order Growth: 28% overall, with HST leading at 47%. Free Cash Flow: $177 million …

IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View

IDEX Corporation exceeded second-quarter 2026 earnings and revenue estimates, driven by strong performance in its Health & Science Technologies segment, particularly in AI-linked data center power and semiconductor markets. The company reported adjusted earnings of $2.32 per share on net sales of $920.6 million …

Idex Releases Q2 2026 Financial Results

Idex Corporation exceeded Wall Street expectations in Q2 2026, reporting adjusted diluted EPS of $2.32 against an estimate of $2.11, and revenue of $920.6M, which was higher than the $905.4M forecast. The company achieved 6.0% revenue growth year-over-year and issued full-year adjusted EPS guidance …

Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Idex (IEX) reported revenue of $920.6 million, up 6.4% over the same period last year. EPS came in at $2.32, compared to $2.07 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $902.43 …

IDEX (NYSE:IEX) Issues FY 2026 Earnings Guidance

IDEX (NYSE:IEX) has issued an optimistic FY 2026 earnings guidance, projecting EPS between $8.70 and $8.85, surpassing the analyst consensus of $8.49. The company also reported strong quarterly results, with EPS of $2.32 and revenue of $920.6 million, both exceeding expectations. Following this announcement, …

Idex (IEX) Q2 Earnings and Revenues Top Estimates

Idex (IEX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

IDEX’s (NYSE:IEX) Q2 CY2026 Sales Beat Estimates, Provides Encouraging Guidance

IDEX's (NYSE:IEX) Q2 CY2026 Sales Beat Estimates, Provides Encouraging Guidance Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter's revenue was optimistic at $931.4 million …